Polygeline: a comprehensive review of its role as a plasma volume expander in clinical practice
DOI:
https://doi.org/10.18203/2320-6012.ijrms20252061Keywords:
Polygeline, Plasma volume expander, ColloidsAbstract
Plasma volume expanders (PVEs) play a crucial role in emergency situations, such as trauma, shock, and major surgery, where rapid restoration of blood volume is essential. The choice between crystalloids and colloids as PVEs depends on various factors, including their pharmacokinetic properties. This review focuses on Polygeline, a synthetic colloid, and aims to discuss its development, physico-chemical properties, pharmacokinetics, clinical efficacy in different scenarios, safety profile, and its place in therapy. The development of polygeline dates to World War I, and its composition involves urea-linked gelatin, sodium chloride, and potassium chloride. The physico-chemical properties of polygeline, such as its average molecular weight, osmolality, and colloidal oncotic pressure, contribute to its unique characteristics, including prolonged intravascular presence and isotonicity with plasma. Compared to crystalloids like normal saline and Ringer's Lactate (RL), polygeline demonstrates a longer duration of action and higher maximum volume expansion, making it a valuable option in various clinical scenarios. The literature review includes studies on polygeline's clinical efficacy in critically ill patients, trauma cases, intra-operative use, haemodialysis, and large-volume paracentesis. Notable findings include its effectiveness in improving hemodynamic stability, especially in trauma patients, and its safe use in haemodialysis to lower catheter-related complications. The safety profile of polygeline appears favourable, with low incidences of anaphylactoid reactions and its safe administration in critically ill patients. In comparison to hydroxyethyl starch (HES), another synthetic colloid, Polygeline seems to have advantages in terms of safety, especially in patients with renal or hepatic impairment.
Metrics
References
Türker FS. Hemorrhagic Shock. In: Clinical Management of Shock-The Science and Art of Physiological Restoration. IntechOpen; 2019. Available at: https://www.intechopen.com/ chapters/65396. Accessed on 15 April 2025.
Shah S, Singh A, Kala S, Shetty R. Polygeline in patients with hypovolemia caused by accidental trauma: a prospective, multicentric, safety study. Int Surg J. 2018;5(4):1432-7. DOI: https://doi.org/10.18203/2349-2902.isj20181125
Owattanapanich N, Chittawatanarat K, Benyakorn T, Sirikun J. Risks and benefits of hypotensive resuscitation in patients with traumatic hemorrhagic shock: a meta-analysis. Scandinavian J Trauma Resuscitation Emerg Med. 2018;26(1):107. DOI: https://doi.org/10.1186/s13049-018-0572-4
Erdman MO, Chardavoyne P, Olympia RP. School Nurses on the Front Lines of Medicine: The Approach to a Student with Severe Traumatic Bleeding. NASN Sch Nurse. 2019;34(5):280-6. DOI: https://doi.org/10.1177/1942602X19837525
Thombre NA, Vishwakarma AV, Jadhav TS, Kshirsagar SJ. Formulation and development of plasma volume expander using natural and modified starch from Solanum tuberosum. Int J Pharm Investig. 2016;6(4):207-17. DOI: https://doi.org/10.4103/2230-973X.195930
Orbegozo Cortés D, Gamarano Barros T, Njimi H, Vincent JL. Crystalloids versus colloids: exploring differences in fluid requirements by systematic review and meta-regression. Anesth Analg. 2015;120(2):389-402. DOI: https://doi.org/10.1213/ANE.0000000000000564
McClelland DB. Safety of human albumin as a constituent of biologic therapeutic products. Transfusion. 1998;38(7):690-9. DOI: https://doi.org/10.1046/j.1537-2995.1998.38798346639.x
Davies MJ. Polygeline. Dev Biol Stand. 1987;67:129-31.
Evans PA, Garnett M, Boffard K, Kirkman E, Jacobson BF. Evaluation of the effect of colloid (Haemaccel) on the bleeding time in the trauma patient. J R Soc Med. 1996;89(2):101P-4. DOI: https://doi.org/10.1177/014107689608900215
Kong F. Haemaccel (Polygeline) Reactions: Anaphylaxis or Anaphylactoid? Aust J Hospital Pharmacy. 2000;30(3):107-8. DOI: https://doi.org/10.1002/jppr2000303107
McGuinness S. A brief history of colloids for fluid therapy. Auckland City Hospital. 2015;19-20.
Davies MJ. Crystalloid or colloid: Does it matter? J Clin Anesthesia. 1989;1(6):464-71. DOI: https://doi.org/10.1016/0952-8180(89)90013-5
Saddler JM, Horsey PJ. The new generation gelatins. Anaesthesia. 1987;42(9):998-1004. DOI: https://doi.org/10.1111/j.1365-2044.1987.tb05376.x
Huskisson L. Intravenous volume replacement: which fluid and why? Arch Dis Childhood. 1992;67(5):649-53. DOI: https://doi.org/10.1136/adc.67.5.649
Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care. 2010;14(5):R185. DOI: https://doi.org/10.1186/cc9293
Davies MJ. Polygeline. Dev Biol Stand. 1987;67:129-31.
Haemaccel SMPC. Available at: https://www.google.com/search?q=Haemaccel+smpc&rlz=1C1JJTC_enIN1056IN1056&oq=Haemaccel+smpc&gs_lcrp=EgZjaHJvbWUyBggAEEUYOTIGCAEQRRg80gEJODAwNmowajE1qAIAsAIA&sourceid=chrome&ie=UTF-8. Assessed on 10 April 2025.
Pohan HT, Lie KC, Santoso WD. An Open Pilot Study of The Efficacy and Safety of Polygeline in Adult Subjects with Dengue Haemorrhagic Fever. Acta Med Indones. 2009;41(2):47-53.
Upadhyay M, Singhi S, Murlidharan J, Kaur N, Majumdar S. Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock. Indian Pediatr. 2005;42(3):223-31.
Stockwell MA, Scott A, Day A, Riley B, Soni N. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure. Anaesthesia. 1992;47(1):7-9. DOI: https://doi.org/10.1111/j.1365-2044.1992.tb01942.x
Singh A, Ali S, Shetty R. Effectiveness and Safety of Polygeline in Patients with Hypovolemia due to Trauma. J Emerg Trauma Shock. 2017;10(3):116-20. DOI: https://doi.org/10.4103/JETS.JETS_120_16
Singh A, Ali S. Polygeline in hypovolemia due to traumatic injury: Results of an open label study in Indian population. Int J Crit Illness Injury Sci. 2016;6(1):21. DOI: https://doi.org/10.4103/2229-5151.177362
Zhu DM, Chen H, Wang W, Chen Y. Application of Polygeline in Pediatric Cardiac Surgery. J Extra Corpor Technol. 1998;30(1):20-4.
Davies MJ, Cronin KD, Domaingue C. Haemodilution for Major Vascular Surgery-Using 3.5% Polygeline (Haemaccel). Anaesth Intensive Care. 1982;10(3):265-70.
Kunwar BR, Bhattacharyya P, Kc N. Efficacy of Equal Volume of Ringer Lactate Versus 3.5% Polymer of Degraded Gelatine Solution (Haemaccel) as Preloading Fluid for Prevention of Hypotension after Spinal Anaesthesia for Lower Segment Cesarean Section. Med J Shree Birendra Hospital. 2011;10(1):1-5. DOI: https://doi.org/10.3126/mjsbh.v10i1.6405
Buturović J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling Hemodialysis Catheters in the Interdialytic Period: Heparin Versus Citrate Versus Polygeline: A Prospective Randomized Study. Artificial Organs. 1998;22(11):945-7.
Lindsay AJ, Burton J, Ray CE. Paracentesis-Induced Circulatory Dysfunction: A Primer for the Interventional Radiologist. Semin Intervent Radiol. 2014;31(3):276-8. DOI: https://doi.org/10.1055/s-0034-1382799
Ginès A, Fernández-Esparrach G, Monescillo A, Vila C, Domènech E, Abecasis R, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology. 1996;111(4):1002-10. DOI: https://doi.org/10.1016/S0016-5085(96)70068-9
Khan MU, Rahim IU, Latif M. Hemaccel as a Cheaper Alternative to Human Albumin for Plasma Expansion during Paracentesis in Cirrhotic patients. P J M H S. 2015;9(3):948-50.
Hydroxyethyl starch (HES) containing medicinal products-referral. European Medicines Agency. Available at: https://www.ema.europa.eu/en/medicines/human/referrals/hydroxyethyl-starch-hes-containing-medicinal-products. Accessed on 15 April 2025.
Pohan HT, Lie KC, Santoso WD, Eppy. An open pilot study of the efficacy and safety of Polygeline in adult subjects with dengue haemorrhagic fever. Acta Med Indones. 2009;41(2):47-53.
Duffy RA, Foroozesh MB, Loflin RD, Ie SR, Icard BL, Tegge AN, et al. Normal saline versus NormosolTM-R in sepsis resuscitation: A retrospective cohort study. J Intensive Care Soc. 2019;20(3):223-30. DOI: https://doi.org/10.1177/1751143718786113
Schöning B, Lorenz W. Prevention of allergoid (cutaneous anaphylactoid) reactions to polygeline (Haemaccel) in orthopaedic patients by premedication with H1- and H2-receptor antagonists. Dev Biol Stand. 1980;48:241-9.
Mitra S, Khandelwal P. Are All Colloids Same? How to Select the Right Colloid? Indian J Anaesth. 2009;53(5):592-607.
Orgev B. A trial of a plasma volume expander (haemaccel) in shock. S Afr Med J. 1969;43(51):1554-6.
Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357(9260):911-6. DOI: https://doi.org/10.1016/S0140-6736(00)04211-2
van Wyk V, Marais A, Diedericks J, van der Walt E, Dumas L, Badenhorst PN, et al. Plasma volume expansion with Haemaccel does not impair haemostasis during reduction mammaplasty. S Afr J Surg. 1998;36(1):22-5.
Place of Polygeline in Fluid Resuscitation: Focus on Hypovolemic Shock. Request PDF. Available at: https://www.researchgate.net/publication/341410229_Place_of_Polygeline_in_Fluid_Resuscitation_Focus_on_Hypovolemic_Shock. Accessed on 17 April 2025.
Stockwell MA, Soni N, Riley B. Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline. 1. Outcome and duration of stay in the intensive care unit. Anaesthesia 1992;47(1):3-6. DOI: https://doi.org/10.1111/j.1365-2044.1992.tb01941.x
Zhu DM, Chen H, Wang W, Chen Y. Application of Polygeline in Pediatric Cardiac Surgery. J Extra Corpor Technol. 1998;30(1):20-4. DOI: https://doi.org/10.1051/ject/199830120
Davies MJ, Cronin KD, Domaingue C. Haemodilution for major vascular surgery--using 3.5% polygeline (Haemaccel). Anaesth Intensive Care 1982;10(3):265-70. DOI: https://doi.org/10.1177/0310057X8201000317
Wahba A, Sendtner E, Birnbaum DE. Fluid resuscitation with Haemaccel vs. human albumin following coronary artery bypass grafting. Thorac Cardiovasc Surg 1996;44(4):178-82. DOI: https://doi.org/10.1055/s-2007-1012012
Svennevig JL. Blood saving--what do we use instead? Fluid substitution during surgery of abdominal aortic aneurysm. Tidsskr Nor Laegeforen 1990;110(18):2362-5.
Bajwa SJS, Kulshrestha A, Jindal R. Co-loading or pre-loading for prevention of hypotension after spinal anaesthesia! a therapeutic dilemma. Anesth Essays Res. 2013;7(2):155-9. DOI: https://doi.org/10.4103/0259-1162.118943
Zahoor-ul-Haq M, Mehraj-Ud D, Darzi MA, Chowdri NA. Experience with isovolemic hemodilution in extensive head and neck surgery. Plast Reconstr Surg. 1995;95(3):479-85. DOI: https://doi.org/10.1097/00006534-199503000-00007
Buturović J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study. Artif Organs 1998;22(11):945-7. DOI: https://doi.org/10.1046/j.1525-1594.1998.06268.x
Boldt J. HES: Is There a Maximal Dose? Transfusion Alternatives in Transfusion. Medicine. 2001;3(4):21-5. DOI: https://doi.org/10.1111/j.1778-428X.2001.tb00041.x
Downloads
Published
How to Cite
Issue
Section
